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Identification and Characterization of Mitochondrial Genome Concatemers in  
AIDS-Associated Lymphomas and Lymphoma Cell Lines 
Felipe Bedoya 
ABSTRACT 
 
 
 
 
Despite recent advances in the understanding of the molecular bases of 
hematological malignancies, the specific mechanisms on how they originate 
and why some subtypes are more prevalent than others still remain to be 
elucidated.  These two important aspects have been even more difficult to 
analyze when dealing with individuals under immune suppression because 
other factors must be considered.  Questions still remain as to why individuals 
with AIDS tend to develop lymphoproliferative disorders differently from those 
observed in individuals under iatrogenic immunosuppressive therapy.  Most of 
lymphomas occurring in transplant recipients are B-cell neoplasias typically 
associated with Epstein-Barr virus (EBV) infection.  In contrast, only about 50% 
of lymphomas of patients with AIDS are associated with lymphotrophic 
herpesviruses such as EBV and Kaposi’s sarcoma-associated herpesvirus 
(KSHV).  No known infectious agent has been detected in the remaining 50% of 
xi 
 
AIDS-associated lymphomas, suggesting the involvement of novel viruses or 
unique molecular mechanisms.  Since most oncogenic viruses persist as 
episomal circular viral genomes in the nuclei of tumor cells, we developed a 
method to visualize and identify covalently closed circular DNA (cccDNA) in 
lymphoma samples.  Although this study revealed no novel viruses, we 
identified concatemers of the mitochondrial genome in all lymphoma samples 
tested.  We further studied in detail one AIDS-associated lymphoma 
(denominated EL) whose mitochondrial DNA primarily consisted of tandem 
head-to-tail genome duplications.  Insertion of cytosine residues was noted in 
the EL mitochondrial genome sequence near the origin of replication.  EL cells 
responded weakly to Fas-apoptotic stimulus, displayed reduced mitochondrial 
activity and mass, and produced higher levels of reactive oxygen species 
(ROS) than control cells.  Screening of several other AIDS-associated 
lymphomas and established lymphoma cell lines revealed a different kind of 
mitochondrial genome concatemers consisting of interlinks of DNA monomer 
molecules.  Concatemers were not detected in normal T-lymphocytes 
suggesting an association with neoplastic transformation.  This dissertation 
describes the two distinct types of mitochondrial genome concatemers 
identified in transformed lymphoid cells and presents a detailed analysis of their 
structure and implications in cellular homeostasis.  
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Introduction 
 
 
 
 
AIDS-associated lymphomas 
 
 After the acknowledgment of HIV as the causative agent of AIDS, it was 
soon recognized that the incidence of lymphoma in HIV-infected patients 
greatly exceeded that in the general population.  The relative risk of non-
Hodgkin’s lymphoma (NHL) is increased 60-200 fold in individuals with AIDS 
(12, 58, 147).  The increased risk of lymphoma has been attributed to multiple 
factors, including the capability of the retrovirus itself to induce transformation 
(86, 101), the cytokine dysregulation and immunosuppression associated with 
the disease (28, 82), and the opportunistic infections caused by lymphotrophic 
γ-herpesviruses such as Epstein–Barr virus (EBV) and Kaposi’s sarcoma-
associated herpesvirus (KSHV) (16, 89, 136, 209).  Several AIDS-associated 
lymphoma subtypes have been classified according to the heterogeneous 
morphology observed in patients.  The WHO categorizes the HIV-associated 
lymphomas into (1) those also occurring in immunocompetent patients, (2) 
those occurring more specifically in HIV-positive patients, and (3) those also 
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occurring in patients with other forms of immunosuppression (Table 1).  
Notably, the majority of these lymphomas are aggressive B-cell neoplasms that 
also occur in immunocompetent patients (17, 148).  
 
 Highly active antiretroviral therapy (HAART) has been reported to both 
increase and decrease the incidence of different lymphoma subtypes.  For 
example, immunoblastic diffuse large B-cell lymphoma (DLBCL) was reduced 
from 38% in the pre-HAART era to 19% in the post-HAART era.  Also, primary 
CNS lymphoma incidence decreased from 28% to 17%.  However, this trend 
has not been observed in all AIDS-related lymphomas, centroblastic DLBCL 
increased from 21% to 44% of cases, and Burkitt’s lymphoma increased from 
4% to 9% (43, 135).  Several studies have shown that the level of 
immunosuppression is also associated to the lymphoma subtype that develops 
in AIDS-patients.  For instance, Burkitt’s and centroblastic DLBCL are 
commonly diagnosed in partially immunodeficient individuals, whereas primary 
effusion lymphoma (PEL) and immunoblastic DLBCL are most often present in 
AIDS-patients suffering from severe immunodeficiency (16, 63).   
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1) Lymphoma also 
occurring in 
immunocompromised 
patients 
• Burkitt's and Burkitt's-like lymphoma 
• Diffuse large B-cell lymphoma (DLBCL) 
• Centroblastic 
• Immunoblastic (including primary CNS  
                lymphoma) 
• Extranodal marginal zone lymphoma of MALT 
type 
• Peripheral T-cell lymphoma 
• Classical Hodgkin's lymphoma (HL) 
2) Lymphoma 
occurring more 
specifically in HIV-
positive patients 
• Primary effusion lymphoma (PEL) 
• Plasmablastic lymphoma of the oral cavity type 
3) Lymphoma also 
occurring in other 
immunodeficiency 
states 
• Polymorphic B-cell lymphoma (PTLD-like) 
 
 
Table 1. Classification of AIDS-associated lymphomas according to WHO. 
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Mitochondria  
 
 Mitochondria are semi-autonomous subcellular organelles essential for 
normal cell physiology and cellular homeostasis (196).  Mitochondria are the 
only organelles that contain their own genome and protein synthesis machinery  
̶  possibly due to their prokaryotic endosymbiont ancestry (98, 196).  They are 
motile and undergo frequent changes in morphology and number through 
fusion and fission events.  Even in the same cell, mitochondria can adopt a 
different range of morphologies (23, 42).  It is in the mitochondria where many 
important metabolic reactions take place such as the urea cycle, lipid 
metabolism, steroid hormone and porphyrin synthesis and interconversion of 
amino acids (164, 195).  Moreover, mitochondria play a central role in complex 
physiological processes including cellular proliferation, differentiation, apoptosis 
(60, 139, 150), and in cellular processes like glucose sensing, insulin regulation 
(15), cellular Ca2+ and ROS homeostasis (123, 176).  Hence, it is not surprising 
that mitochondrial dysfunction has been associated with degenerative 
diseases, aging and cancer (30, 61, 155, 198).   
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Figure 1.  The mitochondrion.  
 
Diagram showing energy (ATP) production from oxidative phosphorylation (OXPHOS), reactive 
oxygen species (ROS) production, and initiation of apoptosis through the mitochondrial 
permeability transition pore (mtPTP). The OXPHOS complexes, designated I to V, are complex 
I (NADH: ubiquinone oxidoreductase), complex II (succinate: ubiquinone oxidoreductase), 
complex III (ubiquinol: cytochrome c oxidoreductase), complex IV (cytochrome c oxidase), and 
complex V (H+-translocating ATP synthase). Pyruvate from glucose enters the mitochondria via 
pyruvate dehydrogenase (PDH), generating acetyl-CoA, which enters the TCA cycle by 
combining with oxaloacetate. Lactate dehydrogenase (LDH) converts excess pyruvate to 
lactate. The voltage-dependent anion channel (VDAC) allows passage of small molecules 
through the inner and outer membrane.  VDAC together with ANT and Bax are thought to come 
together at the mitochondrial inner and outer membrane contact points to create the 
mitochondrial permeability transition pore (mtPTP). The mtPTP interacts with the pro-apoptotic 
Bax, anti-apoptotic Bcl2 and the benzodiazepine receptor (BD). The opening of the mtPTP is 
associated with the release of cytochrome c (Cytc) and several pro-apoptotic factors that 
interact with and activate cytosolic Apaf-1, which then binds to and activates procaspase-9. The 
activated caspase-9 then initiates the proteolytic degradation of cellular proteins ending in 
apoptosis. 
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The mitochondrial genome 
 
 The mammalian mitochondrial genome is a covalently closed circular 
(ccc) duplex DNA (mtDNA) with species-specific contour length of about 5μm 
and nucleotide composition range around 16 Kbp (41, 98).  In humans, the 
mtDNA encodes 13 genes involved in the respiratory chain: 7 genes for 
complex I (NADH-dehydrogenase-ubiquinone reductase): NADH 
dehydrogenase subunit 1 (ND1), ND2, ND3, ND4, ND4L, ND5 and ND6; 1 
gene for complex III (ubiquinol-cytochrome c reductase): cytochrome b; 3 
genes for complex IV (cytochrome c oxidase): Cytochrome c oxidase subunit 1 
(COX1), COX2 and COX3, and 2 genes for complex V (ATP synthetase): 
ATPase6 and Atpase8 (1).   
 
 The mtDNA also encodes 22 transfer RNAs, and two ribosomal RNAs 
known as 12S and 16S rRNAs, that are exclusive for the translation of the 13 
mtDNA protein-coding genes.  All of the peptides and mature transcripts 
derived from the mtDNA are necessary for the proper function of the oxidative 
phosphorylation (OXPHOS) machinery, which is the main biochemical pathway 
for the synthesis of ATP(1, 197).   
 
 In average, 200-10,000 copies of mtDNA are present in a single cell 
depending on cell type and cellular energy demand.  At birth, most (if not all) of 
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the mtDNA copies are identical (homoplasmic) owing to their maternal origin 
(65, 108).  However, degenerative cellular processes (i.e. ageing, disease, etc.) 
have been implicated in the causality of several mitochondrial and mtDNA 
abnormalities, and vice versa (42, 184, 198).  Unlike nuclear DNA, the mtDNA 
is constantly turned over and replicated during the whole cell cycle in normal 
cells (77, 80).  
  
 To date, a large number and ample variety of mtDNA mutations have 
been described, and over 200 human disorders are associated with specific 
point and frame-shift mutations, fusions, partial deletions, or depletion of 
mtDNA.  For instance, several mtDNA mutations have been reported recently in 
human colorectal cancers, and bladder, head, neck and lung tumors (14, 27, 
30, 73, 95, 184).   
 
 Clinically defined syndromes such as MELAS (mitochondrial myopathy, 
encephalopathy, lactic acidosis and stroke-like episodes), MERRF (myoclonus 
epilepsy and ragged-red fibres), and Kearns-Sayre syndrome (retinitis 
pigmentosa, progressive external ophthalmoplegia, ataxia and heart conduction 
defects) have all been directly associated to atypical mtDNA forms (94, 172, 
214).
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Figure 2.  The human mitochondrial genome. 
 
Human mtDNA-encoded genes: NADH dehydrogenase subunits of complex I 
(ND1-ND6 and ND4L), cytochrome b (Cytb) of complex III, cytochrome c 
oxidase subunits of complex IV (COX1-3), ATP synthase subunits 6 and 8 of 
complex V, rRNAs (12S and 16S), and tRNAs (indicated by the one-letter 
amino acid symbol).  Also showing control region (D-loop) and arrows 
indicating the promoters for transcription of the heavy (HSP) and light (LSP) 
strand of mtDNA and the origins of leading (OH) and lagging (OL) strand 
replication.  Modified from reference 31.
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Particularities of the mitochondrial DNA 
 
 In comparison to the nuclear genome, several characteristics have been 
exclusively attributed to the mtDNA: 
 
 
 1) Polyploidy:  Most mammalian cells contain hundreds of mitochondria 
and each mitochondrion contains several copies (2-10) of the mtDNA (131).  It 
is believed that a single individual has identical copies of the mtDNA; however, 
mutations can arise and co-exist with wild-type mtDNA, a phenomenon known 
as heteroplasmy.  Different levels of heteroplasmy have been reported in 
different cell types and tissues due to random segregation of mitochondria (and 
mtDNA) at cell division (174).  In order to produce a particular phenotype (e.g. 
disease), the level of heteroplasmy has to reach a certain percentage known as 
the “threshold effect”, usually around 60-80% of total mtDNA (44, 152). 
 
 
 2) Non-mendelian (maternal) inheritance: A mammalian oocyte 
contains around 100,000 copies of the mitochondrial genome  ̶   a large amount 
of mtDNA in comparison with the mere 100 copies carried in a single sperm cell 
(most of them surrounding the sperm tail to provide ATP for motility) (175).  
Therefore, during fertilization, the sperm head (containing the nucleus) is fused 
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to the egg, and basically no mitochondria are transferred in the process; the 
few mitochondria that could enter in the newly formed zygote are actively 
eliminated by a ubiquitin-dependent mechanism (180, 208).  Recently, new 
evidence showing that paternal mtDNA can be present in the offspring has 
been reported, although the mechanism remains unknown (93, 167). 
 
 
 3) Evolution rate:  There are no histones in the mitochondrion; 
therefore, the mtDNA is less protected than the nuclear genome (168).  
Moreover, the mtDNA is physically associated with the inner mitochondrial 
membrane where damaging ROS are present, and less-efficient DNA repair 
mechanisms have been identified in mitochondria (168, 177, 206).  Together, 
these reasons explain why the mtDNA has higher mutation rates than the 
nuclear DNA, and provide a hint on how somatic accumulation of mtDNA 
mutations can play a role in human aging and disease.  On the other hand, 
single nucleotide polymorphisms (SNPs) in the mtDNA have been mapped and 
have served as a tool for human population genetics and evolutionary studies 
(62, 201). 
 
 
 4) Divergent genetic code:  Mitochondrial genes are translated by a 
mtDNA-restricted translation machinery that utilizes a genetic code distinct from 
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the universal genetic code.  For example, in mammals, UGA rather than a 
termination codon codes for tryptophan, and AGA and AGG are termination 
codons instead of encoding arginine (7). 
 
 
 5) Gene organization:  One of the main characteristics of mammalian 
mtDNA is its compact gene organization.  All the genes are next to each other 
or separated by a few nucleotides with no introns and no 5’ or 3’ non-coding 
regions (1).  In human mtDNA, overlapping occurs between genes ATPase 6 
and ATPase 8 (46 nt in common), and between ND4 and ND4L (7 nt in 
common) (6) (Figure 2).  And for several genes, the termination codon is added 
by poly-adenylation of the mRNA, since it is not encoded in the mtDNA (32).  
The tRNAs are interspersed between genes and play an important role in RNA 
processing (140).  Post-transcriptional excision of tRNAs from polycistronic 
messages is mediated by the mitochondrial RNase P enzyme (encoded in the 
nucleus).  This process of excision is necessary for the expression of the 
mitochondrial genomic information (45, 189). 
 
 The overall genetic content and organization of vertebrate mitochondrial 
genomes is highly conserved; however, the mtDNA sequence and the position 
of regulatory elements for replication and transcription vary considerably even 
within a single species (168).  Two major non-coding regions are present in the 
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mammalian mtDNA: the D-loop and the origin of replication for the light (L) 
strand (OL).  The D-loop (~1kb) contains the origin of replication for the heavy 
or H-strand (according to its higher guanine content) and the promoters for both 
H- and L-strand transcription (168, 183).  Also, within the D-loop highly 
conserved regions are found throughout several metazoan mtDNAs.  They are 
known as the conserved sequence boxes (CSB I-III) and the termination-
associated sequences (TASs) (47, 168).  The OL is a 30 nucleotide-long 
segment at about two-thirds of the mtDNA (from OH) that is located inside a 
tRNA cluster known as the “WANCY” region (from the amino acids single-letter 
nomenclature) (Figure 3) (34, 47). 
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Figure 3.  Schematic representation of the mammalian D-loop.  
Diagram showing the non-coding regulatory D-loop and transcription 
termination regions.  Also, the main factors and cis-elements involved in 
mtDNA transcription and replication. DNA polymerase-γ (DNApol-γ), exclusive 
for mtDNA replication. The mitochondrial RNA polymerase (POLRMT) binds to 
mitochondrial transcription factors (MTFs) bound to regions upstream of 
promoters for light-strand (LSP) and heavy-strand (HSP1 and HSP2) 
transcription.  RNase P is a ribonucleoprotein that processes the transcripts 
from LSP to generate the primers for heavy-strand replication from its origin 
(OH).  Conserved sequence boxes (CSB I-III) and termination-associated 
sequences (TAS) important for transcription and replication of the heavy-strand. 
14 
 
Mitochondrial DNA transcription 
 
 In human mtDNA, independent promoter regions for transcription 
initiation of each strand have been described (33).  The light-strand (lower 
guanine content) encompasses one promoter region known as LSP, and the 
heavy-strand contains two, HSP1 and HSP2 (32, 33).  Polycistronic precursor 
RNAs (some of them nearly full-genome long) are transcribed from both LSP 
and HSPs by the mitochondrial DNA-dependent RNA polymerase (POLRMT) 
(13).  Mature mRNAs and rRNAs are then separated by excision of the tRNAs 
(flanking all the protein-coding genes).  Processing of the mitochondrial RNA 
precursors is carried out by RNase P.  This mechanism of RNA processing has 
been described as a “tRNA punctuation model” (13, 140, 189).   
 
 Since POLRMT cannot directly bind DNA and initiate transcription on its 
own, it requires assistance from mitochondrial transcription factors (mtTFA and 
mtTFB) that associate with specific regions upstream of the mtDNA promoters 
(5, 46).  Although ubiquitous expression, there is substantial evidence 
indicating that the mammalian mitochondrial transcription machinery is 
differentially regulated throughout tissues (48, 161).  Notably, all the proteins 
involved in mtDNA transcription and production of mature mtRNAs are encoded 
in the nuclear genome (156). 
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 Since mitochondrial gene expression is essential for OXPHOS, an 
appealing idea, that has not been fully addressed so far, is how mtDNA 
transcription is coordinated with cellular energy demand.  Different cell and 
tissue types have energetic demands that vary according to their physiological 
state, which in turn require different rates of mitochondrial biogenesis (165, 
194).  The mechanisms that govern mitochondrial biogenesis are poorly 
understood; however, some factors and pathways have been characterized for 
specific situations.  During cellular proliferation, for example, upregulation of 
mitochondrial and nuclear genes necessary for the proper assembly and 
function of the OXPHOS system have been documented (13, 163). This 
process requires the participation of protein activators such as nuclear 
respiratory factors 1 and 2 (NRF-1 and NRF-2), CREB, Sp-1 and others (160, 
162).  Equally necessary, are coactivators that interact with nuclear DNA-
binding proteins such as PGC-1α and PRC, in order to regulate gene 
transcription in response to environmental and proliferative signals (2, 83, 160).  
 
 MtDNA-transcription has been shown to be also regulated by 
intracellular ATP levels (66, 128, 192).  Shuey et al. demonstrated that a 
“sensing mechanism” of the amounts of ATP is responsible for the differential 
expression of mitochondrial transcripts, since ATP is required 15- to 20-fold 
more over the other NTPs for transcription (170).  Furthermore, recent evidence 
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shows that differential transcription from LSP versus HSP1 occurs depending 
on ATP availability, resulting in altered mRNA and rRNA profiles (51, 134). 
 
 
 
Mitochondrial DNA replication 
 
 Mitochondria possess a unique protein system devoted exclusively to 
mtDNA replication.  Most of the components of this repertoire have been 
characterized; however, some elements still remain to be identified since there 
seems to be no apparent mitochondrial counterpart for the corresponding 
nuclear enzymatic activity (e.g. primase for mtDNA light-chain synthesis) (46).  
An important finding in the study of mtDNA is that replication is totally 
dependent on transcription.  This is due to the fact that replication of the heavy 
strand at the origin (OH) is primed by a short RNA transcribed from the LSP 
region (24, 25).  This phenomenon has been demonstrated by several groups.  
Chang D. et al. showed that using mitochondrial transcription assays in vitro 
some of the nascent transcripts remain bound to the mtDNA at the OH (26). And 
Kang et al. detected in vivo RNA-primed DNA strands using the polymerase 
chain reaction analysis (81).   
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 Although the exact mechanism is still under intense debate, two major 
models of mtDNA replication have been proposed (31). The first one (in terms 
of years from publication) is the strand-displacement replication, and the other 
is the strand-coupled replication.  The strand-displacement mechanism was 
initially proposed in 1982 by Clayton et al. from direct observation of purified 
mtDNA by electron microscopy (34).  This mode of mtDNA replication 
resembles to that of bacterial plasmids (e.g. ColE1), but is different from that of 
chromosomal DNA replication of both eukaryotes and eubacteria.  It posits that 
replication of the heavy- (leading) strand initiates at OH and proceeds 
unidirectionally until it reaches two-thirds of the genome, where the origin of the 
light- (lagging) strand (OL) is exposed on the displaced parental strand, 
initiating replication in the opposite direction (Figure 4).  This model, also called 
the asynchronous, strand-asymmetric replication model, introduces the concept 
of a displacement loop (D-loop) observed at high frequency in the purified 
mtDNA analyzed.  The D-loop was described as a third short heavy DNA strand 
associated to the parental mtDNA of about 1Kb of length and presumably 
formed by 5’ to 3’ mtDNA synthesis arrest at the termination-associated 
sequences (TASs) (168).  D-loops of different size have also been detected in 
mtDNA from other species (100, 159).
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Figure 4.  Strand-displacement model of mammalian mtDNA replication.  
Closed circular mtDNA enters replication by formation of D-loop.  Migration of 
the heavy-strand continues unidirectionally displacing the parental strand until it 
reaches two-thirds of the mtDNA, where the origin for light-strand (OL) is 
exposed initiating replication in the opposite direction.  
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 The strand-coupled mechanism of replication was proposed more 
recently by Jacobs and colleagues (70).  It is based on the detection of 
replicative mtDNA intermediates in 2D-gels.  This technique separates DNA 
fragments based on size and shape.  Therefore, replication intermediates are 
expected to resolve in predictable ways.  In case both DNA strands replicate 
simultaneously they tend to form a replication fork, which can be detected as a 
“Y arc” in 2D-gels.  Such Y arcs were unambiguously identified when analyzing 
mtDNA from human placenta and mouse liver, underscoring the existence of a 
strand-synchronous replication mechanism; however, single-stranded 
intermediates were also detected meaning that a combination, rather than a 
mutually exclusive mode, of both mechanisms might be present in mammalian 
mitochondria (149) (Figure 5). 
 
 An interesting observation perhaps is that not all genes required for 
mammalian mtDNA replication have evolved from a prokaryotic ancestor.  For 
example, POLRMT, the catalytic subunit of mtDNA polymerase (POLγA), and 
the mtDNA helicase (TWINKLE) are similar to proteins encoded by 
bacteriophages of the T-odd lineage, which include bacteriophages T3 and T7.  
Therefore, it has been proposed that some genes necessary for replication and 
expression of the mtDNA were acquired from a T-odd phage ancestor early in 
the evolution of eukaryotic organisms, possibly during the time when 
mitochondrial endosymbiosis occurred (21, 171).
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Figure 5.  Strand-coupled model of mammalian mtDNA replication.  
Closed circular mtDNA enters replication by formation of a D-loop that 
facilitates bidirectional polymerization of leading and lagging strands from origin 
OH (it could also start from OL) at the same time (synchronous).  Migration 
could proceed around the genome with lagging-strand replication being the 
result of multiple short-fragment (‘Okazaki’) synthesis.
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Oxidative phosphorylation 
 
 Mitochondria generate energy by oxidizing metabolites derived from our 
dietary carbohydrates (TCA cycle) and fats (β-oxidation) to generate heat and 
ATP (Figure 1) (198).  Embedded in the inner mitochondrial membrane, there is 
a system of electron carrier complexes, also known as the electron transport 
chain (ETC).  The main function of the ETC is to transfer electrons by a multi-
step redox process from TCA cycle products (NADH and FADH2) to oxygen, 
which is reduced to water (36, 49, 198).  Electrons are initially donated from 
NADH and FADH2 to complex I (NADH dehydrogenase) or to complex II 
(succinate dehydrogenase), respectively.  Ubiquinone (also coenzyme Q or 
CoQ) carries these electrons to give ubisemiquinone (CoQH•) and then 
ubiquinol (CoQH2).  Ubiquinol transfers its electrons to complex III 
(ubiquinol:cytochrome c oxidoreductase), which transfers them to cytochrome 
c, an electron carrier protein located within the intermembrane space.  Then, 
cytochrome c carries the electrons to complex IV (cytochrome c oxidase or 
COX) and finally to ½O2 to give H2O.  In order to transfer electrons, each ETC 
complex contains multiple electron carriers.  Complexes I, II, and III encompass 
several iron-sulfur (Fe-S) centers, whereas complexes III and IV contain the b + 
c1 and a + a3 cytochromes, respectively (169, 199, 200, 202).  
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 The energy released by the flow of electrons through the ETC is used to 
pump protons out of the mitochondrial inner membrane through complexes I, 
III, and IV.  The efflux of protons creates a pH gradient and an electrochemical 
gradient across the mitochondrial inner membrane.  This proton gradient is 
harnessed by complex V (F0F1 ATP synthase) for ATP production.  As protons 
flow back into the mitochondrial matrix through a proton channel in complex V, 
ADP and inorganic phosphate (Pi) are bound, condensed, and released in the 
matrix as ATP.  Then, matrix ATP is exchanged for cytosolic ADP through the 
adenine nucleotide translocator (ANT) (Figure 1).  As protons flow through the 
ATP synthase proton channel, the proton gradient is depolarized.  Since the 
ETC is coupled to ATP synthesis, this process is known as oxidative 
phosphorylation (OXPHOS).  The coupling efficiency of the OXPHOS system 
determines the efficiency of producing ATP from dietary calories (36, 172, 198, 
202). 
 
 
 
Mitochondria and cancer 
 
 Cancer cells utilize glycolytic pathways for energy generation while 
upregulating their aerobic respiratory activity.  This metabolic change 
discovered by Otto Warburg over 60 years ago, was one of the first phenotypic 
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alterations recognized in cancerous cells that confers a survival advantage (59, 
204, 215).  Warburg took advantage of new techniques for simultaneously 
measuring gas consumption and lactate production in tumor slices either in the 
presence or absence of oxygen.  Surprisingly, in the presence of oxygen, the 
rapidly growing tumor cells consumed glucose at a higher rate and secreted 
elevated amounts of lactate compared to normal cells (204).  More recently, 
Positron Emission Tomography (PET) imaging technique of fast-growing and 
metastatic human cancers using the glucose analogue tracer 18-
fluorodeoxyglucose (FDG) has confirmed Warburg’s observations (57, 119, 
129).   
 
 The first compelling evidence that mitochondrial dysfunction was 
associated with tumorigenesis was presented less than a decade ago when 
mutations in succinate dehydrogenase (SDH) or fumarate hydratase (FH), both 
enzymes of the TCA cycle, were found to be initiating events of familial 
paraganglioma or leiomyoma and of papillary renal cell cancer, respectively 
(10, 188).  To demonstrate that mtDNA mutations can also contribute to the 
oncogenicity of tumors, a known pathogenic mtDNA mutation was introduced 
into the prostate cancer cell line PC3, which resulted in increased 
tumorigenicity (143).  Furthermore, neoplastic transformation has been found to 
produce marked changes in the expression of both nuclear and mitochondrial 
OXPHOS genes (133, 190).  These changes have been also proposed to occur 
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in tumors developed in a tissue-specific fashion (14, 27, 198).  A study 
performed in Caenorhabditis elegans showed that inactivation of the Cytb (a 
mtDNA-encoded gene) subunit of complex II markedly increases mitochondrial 
ROS production (72).  Thus, ROS production appears to be the factor that links 
mitochondrial defects to neoplastic transformation and metastasis (74, 210).  
However, the precise mechanism by which mitochondrial RNA and/or ROS 
levels increase in cancerous cells still remains unclear (35).   
 
 On the other hand, the direct role that mitochondria play in apoptosis has 
been extensively studied during the past two decades.  For instance, loss of 
mitochondrial membrane potential is thought to contribute to cell death by 
disruption of normal mitochondrial function (20, 76, 96).  Further, mitochondrial 
outer membrane permeabilization (MOMP) leads to the release of proapoptotic 
factors such as cytochrome c and AIF.  Therefore, several MOMP inhibitors 
(e.g. Bcl-2, Bcl-XL, VDAC isomers, hexokinase II) have been described and are 
currently targeted in the chemotherapeutic treatment of cancer (3, 53, 203).
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Objectives 
 
 
 
 
 In comparison to the immunocompetent population, AIDS and post-
transplant patients have a significant increase of developing virus-induced 
cancers.  Lymphoproliferative disorders (LD) in particular, have been found to 
be diagnosed more frequently than other types of neoplasias.  Nevertheless, it 
is still unknown why some LD subtypes are more prevalent than others in AIDS 
versus post-transplant patients.  The discovery of new viruses associated with 
cancer during the last two decades and the immunosuppressive state of these 
individuals suggest that unidentified infectious agents might be responsible for 
inducing neoplastic transformation within this context. 
 
 Since γ-herpesviruses (e.g. KSHV and EBV) have been directly linked to 
specific cases of LD in humans (16, 136, 166), one of our main goals was to 
determine whether EBV- and KSHV-negative AIDS-associated lymphomas 
could be caused by a large DNA virus.  Since γ-herpesviruses are maintained 
as circularized extrachromosomal nuclear genome copies during latency (37), it 
was investigated whether these LD samples could contain novel episomal 
26 
 
DNA.  Despite the fact that no novel DNA was detected in the samples tested, 
dimers and concatemers of the mitochondrial genome were identified.  
Furthermore, independent of HIV infection, established lymphoma cell lines 
also harbored this type of mtDNA.  In this dissertation, a detailed analysis of the 
mtDNA concatemers identified in a case of AIDS-associated lymphoma (EL) is 
presented.  This work also shows evidence that formation of mtDNA 
concatemers and dimers are associated with neoplastic transformation by 
immortalizing normal human T-cells with Herpesvirus saimiri.  Further studies 
on this area might reveal a new avenue for the therapeutic treatment of 
lymphoma. 
 
The following aims were designed for this dissertation project: 
 
1. To characterize the cccDNA identified in a case of EBV- and KSHV-negative 
AIDS-associated lymphoma (EL). 
 
2. To determine if mitochondrial genome concatemers can influence 
mitochondrial and cellular function. 
 
3. To determine if mitochondrial genome concatemers are associated with 
immortalization of normal human T-cells with Herpesvirus saimiri. 
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Materials and methods 
 
 
 
 
Primary AIDS-associated lymphomas and human T-cell samples 
Twelve non-Hodgkin’s lymphoma samples from HIV-positive patients 
were obtained through the Division of Cancer Treatment and Diagnosis at the 
National Cancer Institute.  Samples were cultured in RPMI 1640 medium 
supplemented with 4 mM L-glutamine, 10% fetal bovine serum and 50μg/ml 
gentamycin.  Peripheral blood mononuclear cells were isolated from blood bank 
donor samples and T-cell cultures were obtained by PHA stimulation (10 μg/ml) 
of mononuclear cells for 3 days, then cultured in medium containing 50U/ml of 
IL-2. 
 
 
Method for detection of cccDNA 
Live lymphoid or AIDS-associated lymphoma cells were selected by 
Lymphoprep™ (ProGen), according to manufacturer’s protocol.  1x106 cells 
were loaded in each well of a vertical 0.8% agarose gel in 10% Ficoll buffer 
(54).  Cell lysis buffer containing 5% Ficoll, 1% SDS, 1mg/ml pronase and 
28 
 
0.05% xylene cyanol green was layered on top of the cell samples. 
Electrophoresis was carried at 0.8 V/cm for 3 h, then increased to 7.5 V/cm for 
15 h at 4°C.  The gel was stained with 20 µl of SYBRGreenTM Nucleic Acid 
Stain (Lonza Rockland, Inc., Rockland, ME) diluted in 200 ml of 1X TBE buffer 
for 1 hr.  Then, the gel was de-stained in 10 mM Tris, 1 mM EDTA for 30 
minutes and the DNA was visualized using a Molecular Dynamics STORM 
Phosphor Imager (Model 860-PC, Amersham Biosciences, Piscataway, NJ).  
 
 
Southern blot analysis 
 Agarose gels containing electrophoresed DNA were consecutively 
submerged and gently rocked twice for 15 min each in the following solutions: 
1) 0.25 M HCl solution for DNA depurination, 2) 1 M NaCl, 0.5 M NaOH solution 
for DNA denaturation and residual RNA removal, and 3) a neutralizing solution 
containing 0.5 M Tris-HCl (pH 7.0), 1.5 M NaCl. 
 
 Treated gels were vacuum-blotted onto nitrocellulose membranes (125).  
After blotting, the DNA was immobilized on the membrane by baking for 1h in a 
vacuum oven at 80°C.  At this point, the membrane could be either used for 
hybridization or stored at -20°C.  10 ml of a prehybridization buffer is added to 
the membrane at RT for 10 min.  The prehybridization buffer contains 50% 
formamide, 5X SSC (750 mM NaCl, 75 mM sodium citrate), 10X Denhardt’s 
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solution (0.2% bovine serum albumin, 0.2% Ficoll 400 and 0.2% 
polyvinylpyrrollidone), 0.05 M Na3PO4, 0.5 mg/ml salmon sperm (or total E.coli 
DNA), and 0.1% SDS.  10 ml of hybridization buffer are heated at 100°C for 5 
min then cooled down to RT.  The hybridization buffer consists of 50% 
formamide, 5X SSC, 1X Denhardt’s solution, 0.015 M Na3PO4, 0.1 mg/ml 
salmon sperm, 5% dextran sulfate and 0.1% SDS.  Then, prehybridization 
buffer is removed; the radiolabeled probe is added to the hybridization buffer, 
mixed and added to the membrane.  Hybridization is performed for 16-18 h at 
RT.  The membrane is then washed at RT for 3-4 times with a solution 
containing 0.1% SDS and 0.1X SSC.  Finally, the membrane is exposed for 
autoradiography for 16-24 h to a Phosphor Screen and analyzed using a 
Molecular Dynamics STORM Phosphor Imager (Model 860-PC, Amersham 
Biosciences, Piscataway, NJ).  
 
 
Synthesis of a [γ32P]-ATP-radiolabeled probe by 5’-end labeling of DNA 
oligonucleotides  
 Human mtDNA-derived oligonucleotides (Table 2) were mixed, at a final 
concentration of 10 µg/ml, in 1X TE buffer (primer mix).  Then, the radiolabeled 
probe was made by adding in an eppendorf tube 1µl of primer mix to 1µl of 10X 
T4 polynucleotide kinase buffer, 1 µl (10U) of T4 kinase and 7 µl of [γ32P]-dATP 
isotope.  The mixture was incubated for 30 min at 37°C. Then, 40 µl of a 
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solution (stop buffer) consisting of 20 mM NaCl, 50 mM EDTA, 20 mM Tris-HCl 
(pH 7.5), 1% SDS and 0.25% dextran blue, were added.  The radiolabeled 
probe was kept at RT for hybridization. 
 
 
Isolation of cccDNA by alkaline cell lysis and CsCl-EtBr gradient 
5x108 cells were centrifuged at 500 x g for 15 min and resuspended in 
10 ml 1X PBS.  Five ml of an alkaline buffer solution containing 50 mM NaCl,   
2 mM EDTA, 1% SDS and 30 mM NaOH were added to the cells and the 
mixture was vortexed for 2 min and incubated at 30°C for 30 min.  Then, the 
mixture was neutralized by addition of 80.4 μl of 1 M Tris (pH 7.0) and 200 μl of 
5 M NaCl.  Proteinase K (60 μg/ml) was added and mixture was incubated at 
37°C for 30 min.  DNA was extracted with an equal volume of 24:24:1 
phenol:chloroform:isoamyl alcohol solution followed by extraction with 
chloroform.  DNA was then precipitated by centrifugation at 20,000 rpm at 4°C 
with 2.5 volumes of 95% ethanol.  DNA was air-dried and pellet was 
resuspended in a 1X TE solution.  Then, cesium chloride (CsCl) (1.55 g/ml final 
density) and ethidium bromide (EtBr) (1μg/ml final concentration) were added.  
The mixture was centrifuged at 45,000 rpm in a Beckman L7-75, VTi65 rotor for 
72 h at 20°C.  After 3 days, 200 µl fractions from higher density (bottom of the 
tube) to lower density (top of the tube) were collected in a 96-well plate and 
aliquots from each fraction were analyzed by electrophoresis in a 0.8% agarose 
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gel.  Fractions corresponding to cccDNA were further purified by repeated 
extractions with 1 volume 5M NaCl isopropanol.  The mixture containing the 
cccDNA (stripped of EtBr) was mixed with 2.5 volumes of 95% ethanol, 
centrifuged at 20,000 x g for 30 min at 4°C, and the pellet was resuspended in 
1X TE buffer. 
 
 
Cloning of fragments from EL cccDNA 
 Purified EL cccDNA was electrophoresed in a 0.8% low-melting 
temperature agarose gel for 18 h at 22V, 4°C.  The gel was stained with 
SYBRGreenTM and DNA visualized in a UV-box.  The band corresponding to 
high MW cccDNA was cut out from the gel and incubated at 65°C for 10 min. 
The cccDNA was purified by phenol/chloroform extraction and ethanol 
precipitation.  Cloning of EL cccDNA was performed by restriction digestion 
using the four-base-cutter endonuclease Mbo I followed by T4-ligation to Bam 
HI-digested and dephosphorylated pBluescript® II KS vector.  Ligation mixture 
was phenol/chloroform extracted, ethanol precipitated and resuspended in 10 
µl of nuclease-free water. 
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Electroporation of competent E. coli and selection of transformants 
1 µl of ligated DNA was mixed with 10 µl of competent E. coli 
(ElectroMAX DH10B strain) and incubated on ice for 10 min.  The suspension 
was put in a 1-mm electrode-gap cuvette and electroporated at 1,500 V using 
an Eppendorf Electroporator 2510.  Cells were incubated for 1h at 37°C in 500 
µl of SOC medium (20 g/L bacto-tryptone, 5 g/L yeast extract, 0.5 g NaCl, 2.5 
mM KCl, pH 7.0).  Different dilutions of electroporated cells to SOC medium 
(1:1, 1:10 and 1:100) were plated in agar plates containing ampicillin (100 
µg/ml final concentration), 5-bromo-4-chloro-3-inodlyl-β-D-galactopyranoside 
(X-gal) to a final concentration of 80 μg/ml (prepared in dimethylformamide, 
DMF), and isopropyl-1-thio-β-D-galactopyranoside (IPTG) to a final 
concentration of 20 mM (prepared in sterile ddH2O).  Finally, the plates were 
incubated overnight at 37°C and transformants containing EL cccDNA 
fragments were selected by blue-white color screening. 
 
 
PCR analysis 
Purified cccDNA was electrophoresed in a low-melting temperature 0.8% 
agarose gel and ran overnight at 4°C and 22 V.  After 16 h, gel staining and 
DNA visualization in a UV-box were performed.  The gel fractions containing 
cccDNA for both monomers and concatemers were cut out and melted at 65°C 
for 10 min, then cccDNA was phenol/chloroform extracted and ethanol 
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precipitated.  Oligonucleotides were used either for amplification or as probes 
for Southern blotting (Table 2) (151):  PCR products were electrophoresed in a 
0.8% agarose gel to confirm size (in comparison to predicted size from official 
human mtDNA sequence).  Then, PCR products were sequenced and analyzed 
using CLC Workbench 3®. 
 
Name Sequence Position (3'-end) 
2F 5’CGATCAACCTCACCACCTCT3’ 1245 
2R 5’TGGACAACCAGCTATCACCA3’ 2007 
3F  5’GGACTAACCCCTATACCTTCTGC3’ 1854  
3R  5’GGCAGGTCAATTTCACTGGT3’ 2669  
4F  5’AAATCTTACCCCGCCTGTTT3’ 2499  
4R 5’AGGAATGCCATTGCGATTAG3’  3346  
5F  5’TACTTCACAAAGCGCCTTCC3’ 3169  
5R 5’ATGAAGAATAGGGCGAAGGG3’  3961  
6F  5’TGGCTCTTTAACCTCTCCA3’ 3796 
6R  5’AAGGATTATGGATGCGGTTG3’ 4654  
7F 5’ACTAATTAATCCCCTGGCCC3’ 4485 
7R 5’CCTGGGGTGGGTTTTGTATG3’  5420 
8F 5’CTAACCGGCTTTTTGCCC3’  5255  
8R  5’ACCTAGAAGGTTGCCTGGCT3’ 6031  
9F  5’GAGGCCTAACCCCTGTCTTT3’ 5855  
9R  5’ATTCCGAAGCCTGGTAGGAT3’ 6642  
10F  5’CTCTTCGTCTGATCCGTCCT3’ 6469  
10R  5’AGCGAAGGCTTCTCAAATCA3’ 7315  
11F  5’ACGCCAAAATCCATTTCACT3’ 7148  
11R  5’CGGGAATTGCATCTGTTTTT3’ 8095  
12F  5’ACGAGTACACCGACTACGGC3’ 7937 
12R  5’TGGGTGGTTGGTGTAAATGA3’ 8797  
13F 5’TTTCCCCCTCTATTGATCCC3’ 8621 
13R 5’GTGGCCTTGGTATGTGCTTT3’ 9397 
14F 5’CCCACCAATCACATGCCTAT3’  9230  
14R  5’TGTAGCCGTTGAGTTGTGGT3’ 10130  
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15F  5’TCTCCATCTATTGATGAGGGTCT3’ 9989  
15R  5’AATTAGGCTGTGGGTGGTTG3’  10837 
16F  5’GCCATACTAGTCTTTGCCGC3’ 10672  
16R  5’TTGAGAATGAGTGTGAGGCG3’ 11472  
17F 5’TCACTCTCACTGCCCAAGAA3’ 11314 
17R 5’GGAGAATGGGGGATAGGTGT3’ 12076 
18F 5’TATCACTCTCCTACTTACAG3’  11948  
18R  5’AGAAGGTTATAATTCCTACG3’ 12772  
19F  5’AAACAACCCAGCTCTCCCTAA3’ 12571  
19R  5’TCGATGATGTGGTCTTTGGA3’ 13507  
20F  5’ACATCTGTACCCACGCCTTC3’ 13338  
20R  5’AGAGGGGTCAGGGTTCATTC3’ 14268  
21F 5’GCATAATTAAACTTTACTTC3’  14000  
21R  5’AGAATATTGAGGCGCCATTG3’ 14998  
22F 5’TGAAACTTCGGCTCACTCCT3’ 14856 
22R 5’AGCTTTGGGTGCTAATGGTG3’ 15978 
23F 5’TCATTGGACAAGTAGCATCC3’  15811  
23R  5’GAGTGGTTAATAGGGTGATAG3’  5 
24F  5’CACCATTCTCCGTGAAATCA3’ 16420  
24R  5’AGGCTAAGCGTTTTGAGCTG3’ 775  
 
 
Table 2.  Oligonucleotides used for PCR amplification and sequencing of 
EL cccDNA and mtDNA of normal T-cells. 
3’-end positions are relative to the revised Cambridge reference sequence of 
the human mtDNA available at www.mitomap.org.
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DNA sequencing 
 We submitted all EL cccDNA-derived clones and purified PCR products 
for sequencing to the Molecular Biology core facility at the H. Lee Moffitt 
Cancer Center and Research Institute. 
 
 
Electron microscopy 
Mitochondrial DNA samples were prepared for electron microscope 
imaging using a modified Kleinschmidt protocol (99, 213).  DNA was mixed with 
ammonium acetate and cytochrome C, placed on a piece of parafilm to allow a 
protein monolayer to form.  A carbon coated electron microscopy grid is put in 
contact with the surface of the sample.  Grids were washed with a solution of 
95% ethanol/50 uM uranyl acetate.  Grids were then either visualized as is or 
rotary metal shadowed with tungsten in an Edwards Auto 306 vacuum 
evaporator.  The length of the DNA molecules was confirmed by comparison to 
plasmids of known length.  The grids were imaged in a Hitachi H7500 TEM 
equipped with an Advanced Microscopy Techniques XR60 CCD camera.  The 
NIH Image J was used to trace the backbone of the DNA molecules and the 
DNA length was calculated (EM was performed by Troy Lund and Stephen 
Jett). 
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Flow cytometry analysis for characterization of EL cells 
 1x106  EL cells and normal T-cells for controls, were resuspended in 5ml 
of staining solution containing  1X PBS, 0.1% (w/v) NaN3 and 1.0% (w/v) 
bovine serum albumin (BSA; fraction V) on ice.  Then, cells were fluorescently 
labeled using staining media containing 10 µl of each of the FITC-conjugated 
antibodies used and isotype (IgG1 and IgG2) for controls, diluted to the 
appropriate concentrations.  Cell suspensions were analyzed in a BD 
FACSCaliburTM Flow cytometer.  Monoclonal mouse or goat anti-human 
antibodies for the following markers were used: CD2, CD15, CD45, CD8, 
CD10, CD19, CD20, CD22, CD33, HLA-DR, CD13, CD14. 
 
 
Flow cytometry analysis of mitochondrial factors and properties 
 
1. Mitochondrial membrane potential (Δψm) 
 Δψm was estimated by staining for 15 min at 37°C with cationic lipophilic 
dye 20 nm 3,3'-dihexyloxacarbocyanine iodide (DiOC6; Molecular Probes, 
Eugene, OR; excitation: 488 nm, emission: 525 nm).  Fluorescence of DiOC6 is 
oxidation-independent and correlates with Δψm (182).  Δψm was also 
quantitated by using a potential-dependent J-aggregate-forming lipophilic 
cation, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine iodide 
(JC-1) (173).  JC-1 selectively incorporates into mitochondria, where it forms 
37 
 
monomers (fluorescence in green, 527 nm) or aggregates, at high 
transmembrane potentials (fluorescence in red, 590 nm) (40, 118, 173).  Cells 
were incubated with 0.5 μM JC-1 for 15 min at 37°C before flow cytometry.  
Δψm changes were also confirmed by staining with 1 μM CMXRos (excitation: 
579 nm, emission: 599 nm) and 1 μM tetramethyl rhodamine methylester 
perchlorate (TMRM) (excitation: 543 nm, emission: 567 nm; Molecular Probes). 
Cotreatment with a protonophore, 5 μM carbonyl cyanide m-
chlorophenylhydrazone (mClCCP; Sigma) for 15 min at 37°C resulted in 
decreased DiOC6, CMXRos, TMRM, and JC-1 fluorescence and served as a 
positive control for disruption of Δψm (9).  
 
 
2. Mitochondrial mass  
 Mitochondrial mass was monitored by staining with potential-insensitive 
mitochondrial dyes 50 nM nonyl acridine orange (NAO, excitation: 490 nm, 
emission: 540 nm) or 100 nM MitoTracker green-FM (excitation: 490 nm, 
emission: 516 nm; Molecular Probes).  Samples were analyzed on a Becton 
Dickinson Vantage S/E flow cytometer equipped with an Enterprise II argon 
laser producing two laser lines (emission of 351-364 nm at 60 mW and 
emission of 488 nm at 350 mW) and a Coherent (Santa Clara, CA) 70C 
Spectrum krypton-argon laser operated at 200 mW (emission at 647 nm).  
Dead cells and debris were excluded from the analysis by electronic gating of 
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forward scatter (FSC) and side scatter (SSC) measurements.  Each 
measurement was carried out on 10,000 cells.  
 
 
3. Production of ROS  
 Intracellular amounts of ROS were assessed fluorometrically using 
oxidation-sensitive fluorescent probes 5,6-carboxy-2',7'-dichlorofluorescein-
diacetate (DCFH-DA), dihydrorhodamine 123 (DHR), and dihydroethidium 
(hydroethidine, DHE; Molecular Probes, Eugene, OR) as described (8, 9).  
Cells were incubated with 0.1 μM DHR for 2 min, 1 μM DCFH-DA for 15 min, or 
1 μM DHE for 15 min.  Fluorescence emission from 5,6-carboxy-2',7'-
dichlorofluorescein (DCF; green) or DHR (green) was detected at a wavelength 
of 530 ± 30 nm. Fluorescence emission from oxidized hydroethidine ethidium 
(red), was detected at a wavelength of 605 nm.  While R123, the fluorescent 
product of DHR oxidation, binds selectively to the inner mitochondrial 
membrane, the oxidized products of DCFH-DA and DHE, ethidium and 
dichlorofluorescein (DCF), respectively, remain in the cytosol of living cells. 
DCF and DHE preferentially detect H2O2 and superoxide (O2-), respectively (19, 
90, 153).  
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4. Glutathione levels 
 Intracellular glutathione levels were assessed with 100 μM 
monochlorobimane (excitation: 380 nm/emission: 461 nm) following similar 
protocols for cell staining and sample measurements as in ROS assays.  
 
 
5. Fas-induced apoptosis  
 Apoptosis was induced with Fas Ab CH-11 (MBL, Watertown, MA). 
Briefly, twenty-four hours before assays, cells were fed fresh medium and 
seeded at a density of 2 x 105 cells/ml, and cell death was induced with 50 or 
100 ng/ml anti-Fas mAb CH-11.  Apoptosis was monitored by observing cell 
shrinkage and nuclear fragmentation and was quantified by trypan blue 
exclusion (191).  DNA fragmentation during apoptosis was monitored by 
agarose gel electrophoresis (8).  Apoptosis was also measured by flow 
cytometry after concurrent staining with fluorescein-conjugated annexin V 
(annexin V-FITC; R&D Systems, Minneapolis, MN) and propidium iodide (122, 
193).  Staining with phycoerythrin-conjugated annexin V (annexin V-PE; R&D 
Systems) was used to monitor phosphatidyl serine (PS) externalization in 
parallel with measurement of ROS levels and Δψm, using DHR, DCF, or DiOC6 
fluorescence, respectively.  Staining with annexin V alone or in combination 
with DHR or DiOC6 was conducted in 10mM HEPES (pH 7.4), 140 mM NaCl, 
and 2.5 mM CaCl2. 
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Immortalization of normal human T-cells using Herpesvirus saimiri 
A monolayer of owl monkey kidney (OMK) cells grown in a 100 mm-dish 
were infected with 1x105 pfu/ml of Herpesvirus saimiri (HVS) strain 484-77 for 
virus propagation (127).  After 1h post-infection, supernatant was removed.  
Human peripheral blood leukocytes (PBL) were isolated from blood samples by 
density gradient sedimentation using LymphoprepTM (ProGen) according to 
manufacturer’s instructions.  Then, PBL were cultured in RPMI 1640 cell media 
containing 10% fetal calf serum (FCS), 4 mM L-glutamine, 50 μg/ml gentamycin 
and 0.5 ug/ml of phytohemagglutinin (PHA) for 3 days.  OMK cells showing 
cytopathic effect were overlaid with human T-cells.  Cells were maintained in 
complete media with or without 20U/ml of IL-2 for around two more months 
(181).  Although control uninfected cultures usually died around 3-5 weeks 
post-PHA stimulation, some infected PBL cultures were successfully expanded 
(e.g. T-484 and 3HB6).  After removal of IL-2, these cultures continuously grew 
and were selected for analysis. 
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Results 
 
 
 
Method for detection of large cccDNA of AIDS-associated lymphomas 
 To visualize cccDNA from tumor samples suspensions the vertical gel 
electrophoresis method of Gardella et al. was modified (54).  One million cells 
from each of the twelve AIDS-associated lymphoma samples were run in a 
Gardella gel and the gel was stained with SYBRGreenTM (Figure 6).  In some of 
the samples, DNA bands migrating between the loading well and linear broken 
DNA were observed; this range of these gels contains large (15-250 kb) 
cccDNA.  Four AIDS-associated lymphoma bands were positive for EBV by 
Southern hybridization (not shown) and no longer studied.  The remaining eight 
samples were also negative for KSHV. 
 
 
Identification of large cccDNA in an AIDS-associated lymphoma (EL) that 
does not hybridize with EBV- or KSHV-derived probes 
 To further study the eight EBV- and KSHV-negative lymphomas, 
formation of permanent cell lines was carried out.  After a period of around 3 
months in culture, one lymphoma sample (denominated EL) successfully 
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Figure 6.  The Gardella gel technique and visualization of large cccDNA in 
an AIDS-associated lymphoma sample (EL). 
One million live cells in 10% Ficoll buffer are loaded into a well of a vertical 
agarose gel and digested by overlaying with a lysis buffer containing SDS and 
pronase followed by electrophoresis at 22V for 3 h.  Then, electrophoresis is 
set at 70V for 18 h. Finally, the DNA is visualized by staining with 
SYBRGreenTM.  The three different molecular configurations of DNA are 
indicated.  Right panel shows SYBRGreenTM staining of Gardella gel containing 
unknown episomal DNA from EL cells (arrow) migrating within the range of  
large cccDNA.
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yielded a cell line while all other EBV/KSHV negative lymphoma samples 
eventually died.  Gardella gel analysis of EL cells and the derived cell line 
consistently demonstrated the presence of a large cccDNA unrelated to EBV or 
KSHV (Figures 6 and 7). 
 
 
Phenotypic characterization of EL cells by flow cytometry 
 EL cells were positive for CD3, CD4 and CD45, meaning that they are a 
CD4+ T-cell line.  Other markers tested were: CD8 (specific for CTLs), CD16 
(specific for NK cells, neutrophils, monocytes, and macrophages), CD19, 
CD20, CD22 (for B-cells), CD33 (for myeloid cells) and HLA-DR (for APCs).  
IgG1 and IgG2 were used as isotype controls (Figure 8).   
 
 
The EL cccDNA consists of mitochondrial DNA 
 To determine the sequence of the EL cccDNA, the cells were expanded 
in RPMI 1640 10% FCS without IL-2.  CccDNA was isolated from EL cells by 
alkaline lysis followed by centrifugation on a CsCl-EtBr density gradient. 
Fractions of the gradient were collected and separated by low melting agarose 
gel electrophoresis.  Figure 9 shows that the higher CsCl density fractions 
corresponding to cccDNA contained two discrete bands and the lower density 
fraction contained smeared linear nuclear DNA as expected. 
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Figure 7.  Southern blotting analysis of EL cccDNA using probes specific 
for both EBV and KSHV. 
Total DNA from Gardella gels was transferred onto nitrocellulose membranes 
for Southern blotting.  Radiolabeled probes specific for (A) EBV or (B) KSHV 
DNA do not hybridize with the large cccDNA identified in EL cells.  
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Figure 8.  EL cells are CD4+ T-lymphocytes.    
Phenotypic characterization of EL cells using flow cytometry analysis shows 
that EL cells are CD4+ T-lymphocytes.  Other markers tested:  IgG2, CD8, 
CD16, CD19, CD20, CD22, CD33, HLA-DR.  
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Figure 9.  Gel electrophoresis analysis of CsCl-EtBr gradient fractions of 
total EL DNA. 
Episomal cccDNA was purified from EL cells by alkaline lysis and CsCl–EtBr 
gradient centrifugation.  Density of gradient fractions decreases from left to 
right.  Fractions were analyzed by agarose gel electrophoresis followed by 
SYBRGreenTM staining.  Figure is representative of 7 independent experiments.  
*High molecular weight genomic DNA; **genomic broken linear DNA front. 
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 DNA was extracted from the molten gel slice corresponding to the two 
cccDNA bands and digested with restriction endonuclease MboI.  The 
restriction fragments were shotgun-cloned into the pBluescript™ vector 
(Stratagene) and the clones were sequenced and analyzed using BLAST 
(Figure 10).  Results indicated that the clones contained 95% (>300 clones) 
human mtDNA and ~5% (~20 clones) human chromosomal DNA randomly 
derived from most human chromosomes, presumably caused by contamination 
from nuclear DNA during collection of fractions (Table 3).  Then, normal T-cells 
were obtained from healthy blood donors and cccDNA was isolated and 
compared with EL DNA.  Gel electrophoresis shows that only one band was 
detected in normal T-cells while EL cccDNA contained two bands (Figure 11A).  
Southern hybridization of this gel using a human-mtDNA probe shows co-
migrating bands (slightly above the 23 kb marker) in both normal T-cell and EL 
DNA.  A slower-migrating cccDNA from EL cells also hybridized with the 
mitochondrial probe (Figure 11B).  These results support our previous data that 
both forms of EL cccDNA were comprised of mtDNA.  Moreover, the data show 
that EL cells contain some monomeric mtDNA and a larger and more abundant 
DNA hybridizing with the mtDNA probe. 
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Figure 10.  Schematic representation of the method performed for 
isolation and analysis of EL cccDNA. 
5 x 108 live cells in 10% Ficoll buffer are digested in an alkaline buffer.  A 
solution containing proteinase K is added to the lysate. Total DNA is purified 
using phenol/chloroform extraction and ethanol precipitation.  Purified DNA is 
then mixed with a solution containing CsCl and EtBr, and ultracentrifuged at 
40,000 x g for 72 h.  At the end of the centrifugation, the bottom of the tube is 
perforated with a sterile needle and fractions (from high to low density) are 
collected in a 96-well plate.  An aliquot from each fraction is then loaded and 
run in an agarose gel.  The gel is stained using SYBRGreenTM and the fractions 
containing cccDNA are identified and further purified for cloning.  
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Chromosome 
Size of 
chromosome 
(Mbp) 
Number of sequences 
obtained from  
EL cccDNA cloning 
1 245 2 
2 242 8 
3 200 2 
4 191 2 
5 180 6 
6 171 2 
7 158 none 
8 148 2 
9 138 3 
10 135 none 
11 134 none 
12 132 none 
13 114 1 
14 106 2 
15 100 none 
16 80 none 
17 80 1 
18 76 none 
19 64 1 
20 62 none 
21 46 none 
22 49 none 
X 154 2 
Y 58 none 
mtDNA 0.016 >300 
 
 
Table 3.  DNA sequencing results of EL cccDNA cloning. 
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Figure 11.  Gel electrophoresis and Southern blotting of purified cccDNA 
from EL and normal T-cells using mtDNA-derived probes. 
A) SYBRGreenTM  staining of purified total cccDNA fractions from EL and 
normal T-cells.  
B) Southern blotting of DNA (from A) using a probe of radiolabeled human 
mtDNA-specific oligonucleotides. 
A) B) 
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The EL cccDNA is formed by tandem duplicated mitochondrial genomes. 
 Electron microscopy analysis of 50 molecules from purified EL circular 
episomal DNA showed superhelical DNA with an average backbone contour 
length of 10.3 μm (Figure 12).  Compared to the human mitochondrial genome 
(contour length of 5 μm) the cccDNA of EL cells consisted mainly of molecules 
equivalent to duplicated mtDNA. 
 
 To confirm that the EL episomal DNA is formed by duplicated tandem 
repeats, inverted repeats or rearranged mitochondrial genomes, full and partial 
digestion using BamHI (a mtDNA-single-cutter restriction enzyme) was 
performed.  Figure 13 shows that complete digestion of EL cccDNA with BamHI 
yields one 16.5 kb band.  Partial digestion yielded two linear bands of 
approximately 16.5 and 33 kb corresponding to putative monomers and dimers 
of mtDNA.  These results confirm our electron microscopy and sequencing data 
that the EL episomal DNA is conformed mainly by duplicated mitochondrial 
genomes organized in head-to-tail tandem orientation.  Several additional 
restriction enzyme digestion data also support this conclusion (not shown). 
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Figure 12.  Electron microscopy of EL cccDNA. 
The contour length of the concatemeric mtDNA (EL cccDNA) was measured 
using the Image Processing and Analysis in Java (ImageJ) software from the 
NIH.  DNA contour length was calculated to be around 10.3 µm.  Similar results 
were obtained measuring the contour length of 50 other molecules.  Note: EM 
was performed by Troy Lund and Stephen Jett.  
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Figure 13.  Complete and partial BamHI-restriction digestion of EL 
cccDNA. 
Banding pattern of fully digested EL cccDNA with BamHI (10U) (mtDNA single 
cutter) at 30, 60 and 90 min resembles that of linear human mtDNA monomer 
(16.5 kbp).  Right panel shows partial digestion of EL cccDNA with BamHI 
(0.1U) stopped at increasing time points (5 s, 10 s, 20 s, 40 s, 1 min, 2min, 
5min, 10 min, 20 min, 40 min, 1 h).  After 5 min, two bands of linear DNA are 
observed representing putative human mtDNA monomers and dimers (16.5 
and 33 kbp respectively).   
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Cytosine insertions are present in the control region of the EL mtDNA 
 To determine whether the EL mtDNA has suffered minor mutations, PCR 
amplification of purified EL cccDNA followed by DNA sequencing were 
performed using specific mtDNA derived oligonucleotides covering the entire 
mitochondrial genome (Table 2).  PCR products of EL and normal T-cell DNA 
were indistinguishable by agarose electrophoresis (not shown) indicating 
absence of large insertions or deletions. 
 
 The D-loop, which is the main regulatory region of mtDNA replication 
and transcription, has a highly-conserved C-stretch sequence (nt 311 to 315) 
known as the conserved sequence box II (CSBII) that has been reported as a 
mutational hotspot in primary tumors (158).  Figure 14 shows that sequencing 
of PCR-amplified EL mtDNA revealed two additional cytosine residues in the 
monomer and in the dimer within the CSBII near the primer of mtDNA 
replication.  Normal T-cells did not contain additional cytosines in the CSBII 
region as shown in the human mtDNA reference sequence. 
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Figure 14.  Multiple sequence alignment analysis of conserved sequence 
box II (CSBII) regions from EL and normal mtDNA. 
Multiple DNA sequence alignments of EL cccDNA (mtDNA concatemers and 
monomers) and normal mtDNA were performed using ClustalX.  Shown, the 
regions from the D-loop conserved sequence box II (CSBII, ranging nts 297-
321) from EL (C): EL mtDNA concatemer, EL (M): EL mtDNA monomer, normal 
T-cell (M): normal T-cell mtDNA, and the human mtDNA reference sequence 
from NCBI. 
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Functional and structural mitochondrial properties of EL cells 
 Figure 15 summarizes various properties of EL cell mitochondria. In 
comparison with Jurkat cells (selected due to reproducibility throughout 
experiments and phenotypic similarity to normal T-cells (8)). EL lymphoma cells 
showed increased ROS and peroxide-induced apoptosis as determined by 
staining with dihydroethidium (DHE) and AnnexinV-Alexa 647, respectively.  
These results suggest an unstable OXPHOS system in EL cells, since ROS 
could leak through uncoupled mitochondrial complexes (I-V), thus augmenting 
intrinsic pro-apoptotic signals.  In contrast, monitoring of TMRM, NAO and 
AnnexinV-Alexa-647 fluorescence indicated that mitochondrial membrane 
potential, mitochondrial mass and Fas-mediated apoptosis were respectively 
reduced in EL cells.  Also, glutathione levels were significantly reduced in EL 
cells, which could explain the overproduction of ROS in these cells since 
glutathione works as a biological ROS scavenger (64). 
 
 
Mitochondrial genome concatemers are present in primary AIDS-
associated lymphomas and lymphoma cell lines 
 Primary AIDS-associated lymphomas and lymphoma cell lines were 
screened for episomal cccDNA using the Gardella technique (Figure 16).  
Southern hybridization detected two bands in control T-cells; a broader and 
slower migrating circular form and a faster migrating linear form.  However, all 
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Figure 15.  Flow cytometric analysis of mitochondrial physiological and 
structural properties. 
Reactive oxygen intermediates (ROI), Fas-induced apoptosis, mitochondrial 
mass, mitochondrial potential and glutathione (GSH) levels in EL lymphoma 
cells relative to Jurkat T-cells used as controls (8).  Data represent mean ± SE 
of 4 independent experiments. * P-value<0.05. 
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Figure 16. Mitochondrial genome concatemers are present in primary 
AIDS-associated lymphomas and lymphoma cell lines.  
Primary AIDS-associated lymphoma samples, various lymphoma cell lines and 
normal peripheral T-cell controls were analyzed by the method of Gardella et al. 
(54).  Southern blotting analysis was performed by using human mtDNA-
specific radiolabeled primer probes.  Samples: AIDS-associated lymphomas 
(2F7, 98-001, 98-002, EL); human body cavity lymphoma tumor cell line 
positive for KSHV (BCBL-1); B-cell Burkitt’s lymphoma (Raji); H. saimiri-
induced rabbit lymphoma (484Th) (126); non-Hodgkin’s lymphoma positive for 
EBV and HIV (EBV-HIV-NHL). 
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lymphoma cell lines contained an additional band co-migrating with EL 
cccDNA.  Therefore, all lymphoma cells encode both monomer and concatemer 
forms of mitochondrial genomes.  Small amounts of broken linear mtDNA were 
also present in all samples probably due to dying of some cells.  The linear 
mitochondrial bands co-migrated with controls indicating lack of tandem 
duplication of mtDNA.  In contrast, EL cells contained a unique larger and very 
strong DNA band, and a faint smaller linear mitochondrial genome.  The 
smaller one was co-migrating with bands from all other cells confirming the 
presence of small amount of monomers in EL cells.  Taken together, all 
lymphoma cell lines encode both mitochondrial genome monomers and 
concatemers consisting of two monomers probably due to interlinking of two 
unit-length mitochondrial circles. 
 
 Total cccDNA was also purified by CsCl-EtBr density gradients from 
established human lymphoma cell lines such as K562 (a chronic myeloid 
leukemia cell line), Raji (an EBV-positive Burkitt’s B-cell lymphoma) and Molt3 
(an acute T-cell lymphoma cell line).  Results show that these cell lines also 
contain mtDNA concatemers, although different monomer/concatemer ratios 
were observed for each sample.  An additional band running lower than 
monomeric mtDNA was obtained in Raji, possibly caused by the presence of 
EBV.  A bar diagram using relative units from densitometric analysis of the gel 
shows monomer and concatemer amounts in comparison to EL (Figure 17). 
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Figure 17.  Gel electrophoresis and densitometric analysis of cccDNA 
from human lymphoma cell lines. 
Total cccDNA was isolated from EL and established cell lines by alkaline cell 
lysis and CsCl-EtBr density gradients.  5 µl of purified cccDNA from each 
sample was electrophoresed in an 0.8% agarose gel for 16 h and stained using 
SYBRGreenTM , then visualized in a UV-light box.  CccDNA bands (monomers 
or concatemers) were quantified by densitometric analysis using Image J and  
plotted on a bar diagram according to relative densitometric units. 
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Mitochondrial genome concatemers are associated with oncogenic 
transformation of lymphoid cells 
 Gardella gel and Southern blotting analyses show that H. saimiri-
immortalized human T-cells (T-484 and 3HB6) contain DNA bands hybridizing 
with the mtDNA-derived radiolabeled probe.  Some bands migrated slower than 
the wild-type mitochondrial genome, representing mtDNA concatemers.  A 
much fainter band was also detected for normal T-cells (Figure 18).  
Densitometric unit mean values between monomers versus concatemers 
present per cell sample were statistically significant (P-values of 0.009 for T-
cells, 0.03 for T-484 and 0.06 for 3HB6).  Also, mean values between 
concatemers present in T-cells versus immortalized cell lines were significant 
(P-values <0.05) (Figure 19).   
 
 
Statistical analysis 
 Student’s t-tests were performed to evaluate relative units from flow 
cytometry assays of EL versus control cells to determine significance level of 
variation in mitochondrial function and factors, and to compare densitometric 
unit mean values of monomers and concatemers, and of concatemer relative 
mean value units in normal versus H. saimiri-immortalized T-cells.  A p-
value<0.05 was considered as significant. 
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Figure 18.  Southern blotting assay of Gardella gel of Herpesvirus saimiri-
immortalized human T-cells reveals the presence of mitochondrial 
genome concatemers. 
Mitochondrial genome concatemers were identified in Herpesvirus saimiri–
immortalized T-cells (T-484 and 3HB6) using the Gardella technique followed 
by Southern blotting using mtDNA-derived oligonucleotides.  Figure is 
representative of 4 independent experiments.
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Figure 19.  Densitometric analysis of mitochondrial DNA from 
Herpesvirus-saimiri-immortalized and normal T-cells.  
Mitochondrial DNA bands (from Gardella gels) of Herpesvirus saimiri-
immortalized (T-484 and 3HB6) and normal T-cells were analyzed by 
densitometry.  Shown, mean ± S.E., and P-values of monomer and concatemer 
mean values for each sample, and of concatemer relative mean value units for 
immortalized versus normal T-cells. 
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Discussion 
 
 
 
Identification of mitochondrial genome concatemers in lymphomas  
 In this study, a method was developed for the visualization of cccDNA in 
mammalian cells based on a cell lysis method previously described (54).  This 
technique requires only 1x106 cells and is ideal for screening large number of 
cell samples.  It is rapid, reliable and can be concurrently harnessed for the 
detection of existing or novel episomes of viruses and for the identification of 
size alterations such as insertions, deletions and concatemerization of mtDNA. 
 
 Mitochondrial genome concatemers were identified in primary tumor 
suspension samples obtained from AIDS-associated lymphoma patients and in 
seven established mammalian lymphoma cell lines.  These concatemers were 
found to be conformed of two kinds.  All lymphoma cells, except EL cells, 
contained mitochondrial genome concatemers as interlinked monomers.  In 
contrast, most EL mitochondrial genomes are comprised of two unit length 
molecules joined in head-to-tail configuration as demonstrated by several 
independent methods such as Gardella gels, mtDNA complete and partial 
digestions, and electron microscopy (Figure 20).
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Figure 20.  Schematic model of mtDNA configurations identified in AIDS-
associated lymphomas and lymphoma cell lines. 
Normal T-cells contain mostly wild-type mtDNA (monomers of 16 kb), EL cells 
contain mostly duplicated mitochondrial genomes (dimers of ~32 kb), and 
concatemers (two or more interlocked mitochondrial genomes, ≥32 kb) were 
observed in AIDS-associated lymphomas and lymphoma cell lines analyzed.  
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Proposed molecular mechanisms of mtDNA concatemer formation 
 Although the specific molecular mechanism for mtDNA concatemer 
formation remains elusive, a considerable amount of evidence has been 
reported on processes associated with mtDNA maintenance and stability which 
might be responsible for the formation of mtDNA concatemers in transformed 
lymphoid cells.  Two mechanisms were proposed: homologous recombination 
of mtDNA and mtDNA replication.    
 
 
1) Homologous recombination of mtDNA 
 Homologous recombination (HR) occurs in all life forms, and is an 
important mechanism for the repair of damaged DNA and maintenance of 
chromosomal integrity (157, 178).  In humans, several cancer-prone genetic 
diseases (e.g. Fanconi anemia and Bloom’s syndrome) are associated with HR 
dysfunction or deficiency (84, 178, 179).  Moreover, mutations in the HR-
mediators BRCA1 and BRCA2 genes have been associated with familial breast 
and ovarian cancer (75).  
 
 Although HR of the nuclear genome of eukaryotes has been extensively 
studied, much less is known about HR in mitochondria.  MtDNA HR has been 
documented for a few organisms (50, 116, 117).  In the yeast Saccharomyces 
cerevisiae, an active process of mtDNA HR has been demonstrated (111, 113).  
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It involves the participation of the mitochondrial homologous recombination 
protein 1 (Mhr1) in the formation of HR intermediates of mtDNA, by pairing 
ssDNA with homologous dsDNA forming heteroduplex joints (113), and the 
resolution of recombination junctions by the cruciform cutting endonuclease 
(Cce1) (88).  Interestingly, Mhr1-dependent formation of concatemeric mtDNA 
was observed when generating mitochondrial homoplasmic yeast cells (112).  
However, mammalian homologues for either one of these proteins still remain 
to be identified. 
 
 A homologue of the bacterial recombinase RecA, targeted to 
mitochondria, has been identified in Arabidopsis thaliana and other eukaryotes 
(85, 137).  Also, a RecA homologue targeted to chloroplasts with HR and repair 
activity was described (22).  In humans, RecA homologues such as RAD51and 
RAD52 have been cloned and are currently under intense investigation; 
however, despite their important role in nuclear HR, none of these proteins has 
been found in mitochondria (110).  Hence, it has been hypothesized that other 
proteins or mechanisms responsible for mtDNA HR (or a similar process) must 
be present in mammalian mitochondria (4).  Several reports have shown that 
HR can also occur in human tissues.  Kraytsberg et al. identified heterologous 
(paternal and maternal) mtDNA in muscle tissue of an individual with paternal 
inheritance of the mitochondrial genome (93).  Kajander et al. detected mtDNA 
HR intermediates in human heart muscle (78).  Campbell and colleagues 
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demonstrated that a human mitochondrial protein related to RecA can catalyze 
HR of the mtDNA in vitro (186).  Furthermore, spontaneously immortalized 
murine and human fibroblasts, and primate and murine established fibroblasts 
cell lines performed HR at frequencies around 100-fold higher than did normal 
cells (187).  Therefore, formation of mtDNA concatemers might occur through 
genetic recombination of monomers of the mitochondrial genome, and 
represents an appealing model to examine within the lymphoma context.   
 
 In two seminal papers describing genetic recombination in E. coli, Potter 
H. et al. showed that DNA molecules of the plasmid ColE1 can be recovered 
from wild-type cells as a set of monomer- and multimer-size rings (145, 146).  
Moreover, they demonstrated that multimers are a product of genetic 
recombination since bacterial host cells lacking a functional RecA gene could 
no longer produce such DNA species (146).  Finally, they proposed that 
multimers are the result of the maturation of Holliday intermediates formed 
between two monomer plasmid molecules (146). 
 
 The elucidation by Mootha and colleagues of a protein compendium for 
mammalian mitochondria showed that around 50% of the proteins that form the 
mitochondrial compartment do not have a bona fide mitochondrial targeting 
sequence (MTS) (141).  Therefore, other mechanism(s) for protein 
translocation analogous to the TIM-TOM system must be present in these 
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organelles (130).  The identification of such mechanisms might explain how 
mostly nuclear proteins such as p53 or STAT3 can take transient residence in 
mitochondria (120, 205).  Thus, recombinases that function in the nucleus 
would also be able to translocate under certain circumstances (e.g. neoplastic 
transformation, oxidative stress, etc.) by the same mechanisms and induce the 
formation of concatemeric mtDNA through genetic recombination.   
 
 
2) MtDNA replication 
 Two models for mammalian mtDNA replication have been proposed: the 
strand-displacement and the strand-coupled models (Figures 4 and 5) (31).  
The strand-displacement model was mainly determined by the analysis of 
replication intermediates using EM (34).  Due to the presence of two separated 
origins of replication (OH for the heavy DNA strand, and OL for the light DNA 
strand), during mtDNA replication, two types of mtDNA progeny have been 
observed: The first one is a duplex circle with a newly synthesized leading 
strand, and the other is a gapped circle with a partially formed lagging strand 
(31).  In both cases, the addition of nucleotides and strand ligation at the end of 
the process of mtDNA replication result in the formation of closed circular 
mtDNA monomer molecules.  Therefore, a defective resolution of mtDNA 
replication intermediates into mature monomer molecules could result in an 
increase in the amount of concatemers.  However, the presence of head-to-tail 
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dimers and concatemers in transformed cells would be more in accordance to 
replication intermediates observed in the strand-coupled model (31, 70).  
Simultaneous bidirectional migration of newly formed leading and lagging 
strands would result in circular dsDNA dimeric or concatemeric intermediates 
that would be then processed to form circular monomers in normal cells. 
 
 It is widely accepted that cells undergoing oncogenic transformation 
have marked differences in mtDNA expression and content (68, 190).  A 
prospect study on mtDNA copy number and risk of non-Hodgkin’s lymphoma 
(NHL) showed that mtDNA amounts are increased in patients with chronic 
lymphocytic leukemia (CLL), in Burkitt’s lymphoma and Epstein-Barr virus-
transformed lymphoblastoid cell lines (97).  Although mtDNA configuration was 
not determined in this study, it is possible that increasing amounts of 
concatemers were also the reason for the overall mtDNA increase detected in 
these NHL samples.   
 
 Defects in several mtDNA-replication factors have been associated to 
human disorders (38).  Mitochondrial genetic diseases can result from defects 
in mtDNA in the form of deletions, point mutations, or depletion.  These 
mutations may be spontaneous, maternally inherited, or a result of inherited 
nuclear defects in genes that maintain the mtDNA (38, 39).  It is possible that 
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formation of mtDNA concatemers results also from defects in one or more of 
these factors in cells undergoing oncogenic transformation.   
 
 Differential expression of A and B subunits of DNApol-γ, mitochondrial 
ssDNA-binding factor (MtssB) and the mtDNA helicase (Twinkle) has been 
reported in leukocytes and in leukemic cell lines in comparison to other human 
tissues (165) (Figures 21 and 22).  Furthermore, mutations and SNPs in the 
gene encoding the catalytic subunit of the mtDNA polymerase, DNApol-γ, have 
been associated with such diverse disorders as progressive external 
ophthalmoplegia (PEO), parkinsonism, Alpers syndrome, mitochondrial 
neurogastrointestinal encephalomyopathy (MNGIE), and sensory ataxic 
neuropathy, dysarthria, and ophthalmoparesis (SANDO) (38, 71, 115).  
However, to date, the effect that mutations or SNPs in DNApol-γ (or another 
factor associated with mtDNA replication) may have during neoplastic 
transformation has not been addressed. 
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Figure 21.  DNApol-γ (subunit A and B) mRNA levels in several human 
tissues and human cell lines (GNF Human Gene Atlas). 
Transcript levels of subunits A and B of DNA polymerase gamma (DNApol-γ) 
were determined for several human tissues and cell lines (ref. GNF Human 
Gene Atlas). Highlighted with brackets, mRNA levels of normal leukocytes and 
leukemic cell lines. To note, DNApol-γ mRNA levels are higher in leukocytes  
(normal and cell lines) than in any other human tissue analyzed.
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Figure 22.  MtssB and Twinkle mRNA levels in several human tissues and 
human cell lines (from GNF Human Gene Atlas). 
Transcript levels of mitochondrial single-stranded DNA binding protein (MtssB) 
and mtDNA helicase (Twinkle) were determined for several human tissues and 
cell lines (GNF Human Gene Atlas).  Highlighted with brackets, mRNA levels of 
normal leukocytes and leukemic cell lines. To note, MtssB and Twinkle mRNA 
levels are higher in normal leukocytes than in any other human tissue analyzed 
(including leukemic cell lines).   
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Cytosine insertions in the mtDNA control region  
 Within the mitochondrial genome, a single major non-coding region 
known as the D-loop, contains the main regulatory sequences for transcription 
and replication initiation (183).  DNApol-γ initiates replication at the origin bound 
with the replication primer, and proceeds along one DNA strand displacing the 
other strand (26, 34).  In EL mitochondrial DNA, one to two cytosine insertions 
were present at a highly conserved sequence block (CSB) within the D-loop, 
known as CSBII.  The presence of the mtDNA replication primer next to the 
CSBII suggests that CSBII might be important during initiation/termination of 
mtDNA replication, serving as a possible docking site for DNApol-γ (46).  
Nevertheless, the lack of an effective method to study mtDNA mutations or 
insertions in vivo has hindered further investigation on this phenomenon, which 
may be attributed to random genetic drift or rapid clonal expansion occurring in 
cells undergoing oncogenic transformation.  Interestingly, insertion of C 
residues in the CSBII has been described as a frequent event in mtDNA 
alterations in human tumors (158).  It could be possible that a higher G-C 
content might affect dissociation of the RNA primer from the DNA, affecting 
termination of DNA replication.  Also, addition of cytosine residues might 
increase the base-pairing binding strength of both DNA strands influencing 
mtDNA termination and/or release of nascent molecules from parental mtDNA. 
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Nucleoside analogues used in the treatment of AIDS affect mtDNA 
stability 
 Highly active antiretroviral therapy (HAART), which includes nucleoside 
analogue reverse transcriptase inhibitors (NRTIs) in combination with other 
agents, has changed AIDS from a lethal illness to a chronic, manageable 
disease (106).  Within the list of NRTIs, azidothymidine (AZT), a thymidine 
analogue that inhibits HIV reverse-transcription, has been one of the most 
widely used antiretroviral drugs in the treatment of AIDS.  Due to substrate 
competitive inhibition, AZT can also function as a DNApol-γ inhibitor (121, 144, 
212) (Figure 23).  AZT treatment could result in the induction of impaired 
mtDNA replication that could promote the formation of mitochondrial genome 
concatemers and/or other mtDNA abnormalities, which may be associated to 
oncogenic transformation in individuals with AIDS.  It is also recognized that 
mitochondrial functions are affected as a result of NRTI therapy (109).  Cardiac 
dysfunction, hepatic failure, skeletal myopathy, lactic acidosis with defective 
mtDNA replication, mtDNA depletion and altered mitochondrial ultrastructure 
have been observed in selected tissues in vivo and in post-HAART patients 
(105, 107).  
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Figure 23.  Inhibition of DNA polymerase gamma by NRTIs (AZT).  
Diagram shows the structure of the mitochondrion.  The nucleoside reverse 
transcriptase inhibitor, AZT, is phosphorylated by thymidine kinase 2 (TK2), the 
mitochondrial isoform, thus initiating a series of steps that lead to the formation 
of the active form. DNApol-γ, is inhibited by NRTI triphosphates (e.g. AZT-TP) 
to deplete mtDNA by competitive inhibition with the normal pool of nucleotide 
triphosphates.  Adapted from reference 106. 
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Mitochondrial genome concatemers influence cellular and mitochondrial 
functions 
 The mtDNA encodes only 1% of the mitochondrial proteins; however, it 
is crucial for mitochondrial stability.  The mtDNA-encoded genes are essential 
subunits for OXPHOS system assembly and function.  Therefore, the mtDNA is 
necessary for cellular energy production in the form of ATP through OXPHOS 
from dietary metabolites (172).   
 
 Variations in the mtDNA are highly detrimental for cellular homeostasis 
(38, 115).  Full and partial deletions of the mtDNA have been reported in 
several conditions including mitochondrial myopathies (69), Kearns-Sayre 
syndrome (104), PEO (214) and Pearson syndrome (154).  More than 200 point 
mutations and rearrangements of the mtDNA have also been associated with 
human disease (29, 103), and some of them have been directly linked to 
tumorigenesis (18, 27).  Penta JS et al. proposed that it is possible that the 
oxidatively stressed environment of tumors may result in high rates of mtDNA 
mutations and reduced expression of mtDNA-encoded polypeptides (142).  
Strikingly, mutated mtDNA in tumors has been found as mostly homoplasmic, 
meaning that all cells within a tumor carry the same mtDNA mutation, a 
phenomenon that suggests selective advantage to these mutations (138).  
Recently, it was reported that particular mtDNA mutations can contribute to 
tumor progression.  Cells bearing a mutation in the mtDNA gene encoding 
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NADH dehydrogenase subunit 6 (ND6), have a defective respiratory complex I 
and subsequently overproduce ROS that increase metastatic potential (73).  
Nevertheless, dimerization or concatemerization of the mtDNA have not been 
related to any cellular disorder so far.  This dissertation shows evidence that 
formation of mtDNA concatemers is associated with changes in mitochondrial 
function and with neoplastic transformation in lymphoid cells.   
 
 In this study, several significant alterations in mitochondrial functions and 
cellular factors associated with mitochondria in EL cells were identified.  
Probably the decrease in Fas-mediated apoptosis is most noteworthy.  It has 
been shown that tumor cells often escape immune surveillance by down-
regulating the Fas pathway or by using it to their advantage (91).  For example, 
some tumors increase Fas ligand (FasL) expression to induce apoptosis of 
infiltrating lymphocytes (92).  Also, some viruses can promote their propagation 
by expressing Fas-inhibitory proteins (11, 185).  In regards to mtDNA, the 
cleavage and cytoplasmic release of cytochrome b (a mtDNA-encoded protein) 
has been directly linked to Fas-induced apoptosis (91).  However, more studies 
are required to evaluate whether these changes in EL cells are a consequence 
of malignant transformation or represent the result of mtDNA duplication and 
mutation. 
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Increased intracellular ROS 
 The role that intracellular ROS play in cellular biology has been 
controversial.  ROS are highly reactive due to the presence of unpaired valence 
shell electrons.  Therefore, during environmental stress, ROS levels increase 
(presumably within the mM range) and cause random deleterious oxidation of 
macromolecules, a condition known as oxidative stress (102, 114).  MtDNA is 
constantly subjected to oxidative damage due to direct exposure to ROS as 
direct byproducts of OXPHOS.  This damage results in mutations in the 
mtDNA, which are associated with aging and various mitochondrial disorders 
(79).  On the other hand, the treatment of human cells with hydrogen peroxide 
results in a transient increase in mtDNA copy number, suggesting that ROS 
can regulate mtDNA replication (207).  Furthermore, the amount of mtDNA 
correlates with ROS levels in cell lines carrying different mouse mtDNA 
haplotypes (132). 
 
 Contrary to their role as inducers of cellular toxicity, several lines of 
evidence have shown that high ROS levels are associated with cell survival by 
deregulation of the PI3-kinase/Akt pathway during tumorigenesis (35, 52).  
Moreover, mitochondrial ROS could also contribute to neoplastic 
transformation, both as a tumor inducer by causing mutations in the nuclear 
DNA in proto-oncogenes and tumor-suppressor genes, and as a tumor 
promoter through promoting cellular proliferation (198).  At low levels (within the 
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µM range), ROS have been found to be active mitogens.  ROS are presumed 
to act through interaction with various kinases including Src kinase, protein 
kinase C, MAPK, and receptor tyrosine kinases, and with several transcription 
factors such as Fos, Jun and NF-κB (124).  A significant reduction of 
glutathione levels was observed in EL cells.  This may be associated with the 
elevation in ROS production, since glutathione works as a biological scavenger 
of ROS (64).  
 
 
 
Herpesvirus saimiri-immortalized human T-cells contain mitochondrial 
genome concatemers 
 In order to determine if cells undergoing transformation were able to 
produce concatemers of mtDNA similar to the ones observed in the primary 
AIDS-associated lymphomas and lymphoma cell lines studied, immortalization 
of normal T-cells by infection with Herpesvirus saimiri was performed.  This 
experimental approach was chosen because it has been successfully used in 
the past to obtain human, rabbit and marmoset transformed T-cell lines (126, 
127, 181). 
 
 Discrete bands of mtDNA concatemers were detected by Southern 
blotting in the T-cell lines T-484 and BH36, immortalized with H.saimiri.  
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Additionally, a fainter band representing a small amount of concatemers was 
also detected in normal T-cells.  This indicates that the process of formation of 
concatemers might also take place under normal conditions; however, 
resolution of concatemers into monomers might be defective in neoplastically 
transformed cells resulting in accumulation of concatemers.  
 
 Statistical analysis of relative densitometric units shows that the mean 
values between concatemer and monomer amounts for each sample is 
significant (P-values<0.005).  This means that there may be an intrinsic 
mechanism that keeps total mtDNA amounts (and possibly 
concatemer/monomer ratios) relatively constant within these cells.  Notably, the 
higher amount of concatemers in immortalized T-cells was also statistically 
significant (P-value<0.002) in comparison to the much lower levels detected in 
normal T-cells.  This implies that formation and maintenance of mtDNA 
concatemers is a condition associated with immortalization of T-cells.  
However, further experiments would be necessary to determine whether 
mtDNA concatemers can promote oncogenic transformation of normal cells, or 
if they result as byproducts of cellular growth and proliferation observed in 
cancer. 
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Proposed mechanism of neoplastic transformation of lymphoid cells by 
formation and maintenance of mtDNA concatemers 
 Cellular homeostasis and energy production rely heavily on mtDNA 
stability (177).  Mutations in the mtDNA have long been linked to the 
development and poor prognosis of various types of cancers (14, 27, 55, 73, 
138).  The physiological significance of mtDNA mutations in cancer cells was 
demonstrated by introducing a known pathogenic mtDNA mutation into the 
prostate cancer cell line PC3 via transmitochondrial cybrid fusions (143).  
Injection of these mutant and wild-type PC3 cybrids into nude mice gave a 
dramatic result.  The PC3 cells containing the normal base (T8993T) barely 
grew at all.  By contrast, the PC3 cybrids with the mutant base (T8993G) 
generated rapidly growing tumors that killed the mice (143).  Staining the 
cellular nodules from both conditions revealed that the mutant tumors produced 
much more ROS than the wild-type nodules.  Thus, underscoring the 
generation of increased ROS, associated with mutant mtDNA, in the 
pathophysiology of cancer (143).   
 
 Neoplastically transformed cells, however, can also harbor non-mutated 
mtDNA (198).  Therefore, the presence of mitochondrial genome concatemers 
may represent an alternative mechanism of increasing intracellular ROS levels, 
as detected in EL cells.  Recently, Lan Q. et al showed that increased mtDNA 
copy number was associated with a higher risk of developing non-Hodking’s 
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lymphoma (NHL) by analyzing blood samples from 208 NHL and healthy 
individuals (97).  This dissertation shows evidence that, independent of 
configuration, overall mtDNA levels are increased in AIDS-associated 
lymphomas, in lymphoma cell lines and in immortalized T-cells.  Formation of 
mtDNA concatemers is also associated with higher mtDNA levels observed in 
these samples.  Furthermore, imbalance and lower coupling efficiency of the 
OXPHOS system have been reported in cells with abnormal mtDNA content 
(67, 211).  Defects in OXPHOS have long been known as causative of 
increased ROS levels (49, 56, 87, 102).  The diffusion of ROS into the nucleus 
can then mutate proto-oncogenes, converting them into functional oncogenes. 
Increased cytosolic and nuclear ROS activate a variety of cellular signal 
transduction factors including NFκB, APE-1, Fos, Jun, and tyrosine kinases, 
which drive the cell into replication.  Consequently, variations in the mtDNA 
(content and/or mutations) capable of affecting the normal function of the 
OXPHOS machinery, result in chronically increased mitochondrial ROS 
production, which can act as both a tumor initiator (mutation of proto-
oncogenes) and tumor promoter (activation of transcription and replication) (87, 
176, 197)  (Figure 24). 
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Figure 24.  Schematic diagram of proposed mechanism of induction of 
oncogenic transformation by formation and maintenance of mitochondrial 
genome concatemers. 
Cells containing mitochondrial genome concatemers show increased mtDNA 
levels (Figure 19) and higher ROS production (Figure 15).  Neoplastically 
transformed cells upregulate mtDNA gene expression (190) generally resulting 
in a defective (uncoupled) OXPHOS system (14, 73), which can also produce 
higher ROS levels.  ROS can inhibit tumor suppressor factors (p16ink4a, p53) 
and induce transcription factor activation (AP-1, NF-B, APE), which results in  
cellular proliferation (176, 198).
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 Finally, these experiments have established a clear correlation between 
mtDNA concatemerization and malignancy of lymphoid cells.  However, it is not 
clear whether concatemerization is a contributing factor to oncogenesis, or 
alternatively, a result of continuing growth of immortalized cells.  Resolution of 
these possible alternatives requires further investigation.  
 
 
 
Summary and future directions 
 The development of techniques to study cccDNAs has been of 
importance in the understanding of the etiology of human diseases.  This 
dissertation describes an experimental approach developed in our laboratory, 
and by which a novel extrachromosomal cccDNA was identified in AIDS-related 
lymphomas and lymphoma cell lines.  This cccDNA is conformed by 
concatemers of the mitochondrial genome.  Moreover, by immortalizing normal 
human lymphocytes with Herpesvirus saimiri, it was demonstrated that 
formation of mitochondrial genome concatemers is associated with oncogenic 
transformation of lymphoid cells.   
 
 In order to determine the relationship between formation of mtDNA 
concatemers and oncogenic transformation, two strategies are proposed.  First, 
the fabrication and study of transmitochondrial cybrids using cells containing 
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either wild-type or concatemeric mtDNA, with similar nuclear backgrounds, will 
determine whether the presence of concatemers is sufficient to induce 
neoplastic transformation.  And second, the study of T-cells immortalized with 
Herpesvirus saimiri could be useful to demonstrate if mtDNA concatemers are 
simply byproducts of cellular immortalization.  Additionally, an increasing time-
point assay after viral infection is proposed to determine when 
concatemerization of the mtDNA takes place in these cells.  Further studies on 
the mechanism of formation and biological significance of mtDNA concatemers 
may provide a new avenue in the chemotherapeutic treatment of lymphoma. 
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